# Investigation of Naltrexone for Pathological Gambling

> **NCT01057862** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 9 (actual)

## Conditions studied

- Pathological Gambling

## Interventions

- **DRUG:** Naltrexone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01057862
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2016-02
- **Final completion:** 2017-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057862, "Investigation of Naltrexone for Pathological Gambling". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01057862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*